Regeneus Ltd News Today

Regeneus Ltd. (AU:CMB) has released an update. Cambium Bio Limited has announced its General Meeting to be held on June 25, 2024, encouraging share...

Regeneus Ltd. (AU:CMB) has released an update. Cambium Bio Limited, previously known as Regeneus Ltd, has announced an upcoming General Meeting for...

Regeneus Ltd. (AU:CMB) has released an update. Cambium Bio Limited, a Sydney-based regenerative medicine company, has announced a proposal to conso...

Regeneus Ltd. (AU:CMB) has released an update. Cambiun Bio Limited, identified by ASX issuer code CMB, has announced a security consolidation for i...

Animal Stem Cell Therapy Market by Type (Dogs Stem Cell Therapy, Horses Stem Cell Therapy, and Others), by Application (Veterinary Hospitals and Research Organizations), and by Region (North America, South America, Europe, Asia Pacific, and Middle Ea

Regeneus Ltd. (AU:CMB) has released an update. Cambium Bio Limited, a clinical-stage regenerative medicine company, has merged with Cambium Medical...

Animal Stem Cell Therapy Market by Type (Dogs Stem Cell Therapy, Horses Stem Cell Therapy, and Others), by Application (Veterinary Hospitals and Research Organizations), and by Region (North America, South America, Europe, Asia Pacific, and Middle Ea

Regeneus Ltd. (AU:RGS) has released an update. Regeneus Ltd., soon to be Cambium Bio Limited, has announced a significant change in shareholding, w...

Regeneus Ltd. (AU:RGS) has released an update. Regeneus Ltd has announced an application for the quotation of over 306 million fully paid ordinary ...

Regeneus Ltd. (AU:RGS) has released an update. Regeneus Ltd, a clinical-stage regenerative medicine company, has announced the successful completio...